JP2011523643A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011523643A5 JP2011523643A5 JP2011510067A JP2011510067A JP2011523643A5 JP 2011523643 A5 JP2011523643 A5 JP 2011523643A5 JP 2011510067 A JP2011510067 A JP 2011510067A JP 2011510067 A JP2011510067 A JP 2011510067A JP 2011523643 A5 JP2011523643 A5 JP 2011523643A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutically acceptable
- acceptable salt
- item
- following formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QZDZEQOMUGMANT-HGRCFPFLSA-N CC(C)(C)OC(N[C@H]([C@H](C(O[C@@H](C1)C(C)=C([C@H](C(C(C)([C@H](C[C@H]2OC[C@]22OC(C)=O)O)[C@@H]2[C@@]2(C3)OC(c4ccccc4)=O)=O)O)C3(C)[C@@]12O)=O)OC(CCCN1CCN(C)CC1)=O)c1ccccc1)=O Chemical compound CC(C)(C)OC(N[C@H]([C@H](C(O[C@@H](C1)C(C)=C([C@H](C(C(C)([C@H](C[C@H]2OC[C@]22OC(C)=O)O)[C@@H]2[C@@]2(C3)OC(c4ccccc4)=O)=O)O)C3(C)[C@@]12O)=O)OC(CCCN1CCN(C)CC1)=O)c1ccccc1)=O QZDZEQOMUGMANT-HGRCFPFLSA-N 0.000 description 1
- UQULALZGMRBUMD-FSBDEDPYSA-N CC(C)(C)OC(N[C@H]([C@H](C(O[C@@H](C1)C(C)=C([C@H](C([C@](C)([C@H](C[C@H]2OC3)O)[C@H]([C@@H]4OC(c5ccccc5)=O)[C@@]23OC(C)=O)=O)O)C(C)(C)[C@@]14O)=O)OC(CCN1CCCCC1)=O)c1ccccc1)=O Chemical compound CC(C)(C)OC(N[C@H]([C@H](C(O[C@@H](C1)C(C)=C([C@H](C([C@](C)([C@H](C[C@H]2OC3)O)[C@H]([C@@H]4OC(c5ccccc5)=O)[C@@]23OC(C)=O)=O)O)C(C)(C)[C@@]14O)=O)OC(CCN1CCCCC1)=O)c1ccccc1)=O UQULALZGMRBUMD-FSBDEDPYSA-N 0.000 description 1
- ORTQFODLPLMDGP-DNCPDDFDSA-N CC(C)(C)OC(N[C@H]([C@H](C(O[C@@H](C1)C(C)=C([C@H](C([C@](C)([C@H](C[C@H]2OC3)O)[C@H]([C@@H]4OC(c5ccccc5)=O)[C@@]23OC(C)=O)=O)O)C(C)(C)[C@@]14O)=O)OC(CN1CCOCC1)=O)c1ccccc1)=O Chemical compound CC(C)(C)OC(N[C@H]([C@H](C(O[C@@H](C1)C(C)=C([C@H](C([C@](C)([C@H](C[C@H]2OC3)O)[C@H]([C@@H]4OC(c5ccccc5)=O)[C@@]23OC(C)=O)=O)O)C(C)(C)[C@@]14O)=O)OC(CN1CCOCC1)=O)c1ccccc1)=O ORTQFODLPLMDGP-DNCPDDFDSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5592908P | 2008-05-23 | 2008-05-23 | |
| US61/055,929 | 2008-05-23 | ||
| PCT/IB2009/006532 WO2009141738A2 (en) | 2008-05-23 | 2009-05-26 | Modified drugs for use in liposomal nanoparticles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014043564A Division JP5744267B2 (ja) | 2008-05-23 | 2014-03-06 | リポソームナノ粒子中で使用するための修飾薬物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011523643A JP2011523643A (ja) | 2011-08-18 |
| JP2011523643A5 true JP2011523643A5 (enExample) | 2012-07-19 |
| JP5542804B2 JP5542804B2 (ja) | 2014-07-09 |
Family
ID=41340622
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011510067A Expired - Fee Related JP5542804B2 (ja) | 2008-05-23 | 2009-05-26 | リポソームナノ粒子中で使用するための修飾薬物 |
| JP2014043564A Expired - Fee Related JP5744267B2 (ja) | 2008-05-23 | 2014-03-06 | リポソームナノ粒子中で使用するための修飾薬物 |
| JP2014146559A Expired - Fee Related JP5992019B2 (ja) | 2008-05-23 | 2014-07-17 | リポソームナノ粒子中で使用するための修飾薬物 |
| JP2016159491A Expired - Fee Related JP6437968B2 (ja) | 2008-05-23 | 2016-08-16 | リポソームナノ粒子中で使用するための修飾薬物 |
| JP2018214441A Pending JP2019048851A (ja) | 2008-05-23 | 2018-11-15 | リポソームナノ粒子中で使用するための修飾薬物 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014043564A Expired - Fee Related JP5744267B2 (ja) | 2008-05-23 | 2014-03-06 | リポソームナノ粒子中で使用するための修飾薬物 |
| JP2014146559A Expired - Fee Related JP5992019B2 (ja) | 2008-05-23 | 2014-07-17 | リポソームナノ粒子中で使用するための修飾薬物 |
| JP2016159491A Expired - Fee Related JP6437968B2 (ja) | 2008-05-23 | 2016-08-16 | リポソームナノ粒子中で使用するための修飾薬物 |
| JP2018214441A Pending JP2019048851A (ja) | 2008-05-23 | 2018-11-15 | リポソームナノ粒子中で使用するための修飾薬物 |
Country Status (9)
| Country | Link |
|---|---|
| US (7) | US8790691B2 (enExample) |
| EP (2) | EP2282724B1 (enExample) |
| JP (5) | JP5542804B2 (enExample) |
| KR (5) | KR20190049930A (enExample) |
| CN (2) | CN102105135B (enExample) |
| CA (3) | CA2989616A1 (enExample) |
| ES (1) | ES2694481T3 (enExample) |
| IL (2) | IL209419A (enExample) |
| WO (1) | WO2009141738A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5542804B2 (ja) * | 2008-05-23 | 2014-07-09 | ザ ユニヴァーシティ オブ ブリティッシュ コロンビア | リポソームナノ粒子中で使用するための修飾薬物 |
| CN102018672B (zh) * | 2010-11-29 | 2013-09-18 | 广州朗圣药业有限公司 | 一种水溶性药物的脂质体冻干组合物及其制备方法 |
| CN102617517B (zh) * | 2011-01-27 | 2015-11-18 | 李勤耕 | 一类新的7,10-o,o-二甲多西紫杉醇衍生物及其应用 |
| EP2667848A1 (en) * | 2011-01-28 | 2013-12-04 | Koninklijke Philips N.V. | Carriers for the local release of hydrophilic prodrugs |
| WO2012166949A1 (en) * | 2011-05-31 | 2012-12-06 | Regents Of The University Of Minnesota | Silicate prodrugs and nanoparticles |
| WO2014058729A1 (en) * | 2012-10-09 | 2014-04-17 | California Institute Of Technology | In vivo and in vitro carbene insertion and nitrene transfer reactions catalyzed by heme enzymes |
| JP2015534464A (ja) | 2012-10-09 | 2015-12-03 | カリフォルニア インスティチュート オブ テクノロジー | ヘム酵素によって触媒されるインビボおよびインビトロオレフィンシクロプロパン化 |
| EP2968145A1 (en) * | 2013-03-13 | 2016-01-20 | Mallinckrodt LLC | Modified docetaxel liposome formulations |
| GB201315321D0 (en) | 2013-08-28 | 2013-10-09 | Koninklijke Nederlandse Akademie Van Wetenschappen | Transduction Buffer |
| US20160229962A1 (en) | 2013-09-30 | 2016-08-11 | Danmarks Tekniske Universitet | Silicone chain extender |
| US9399762B2 (en) | 2014-02-18 | 2016-07-26 | California Institute Of Technology | Methods and systems for sulfimidation or sulfoximidation of organic molecules |
| CN105085437B (zh) * | 2014-05-23 | 2018-07-03 | 上海交通大学 | 3-(1-叔丁氧羰酰哌嗪-4-yl)丙酸的两亲性衍生物及其用途 |
| CN104368011B (zh) * | 2014-11-27 | 2017-05-10 | 东南大学 | 一种药物甜菜碱缀合物、其药物组合物及应用 |
| EP3258913A1 (en) * | 2015-02-17 | 2017-12-27 | Mallinckrodt Nuclear Medicine LLC | Modified docetaxel liposome formulations and uses thereof |
| TWI678213B (zh) * | 2015-07-22 | 2019-12-01 | 美商史倍壯製藥公司 | 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物 |
| US20180344644A1 (en) * | 2015-09-21 | 2018-12-06 | Mallinckrodt Llc | Improved stability of liposome formulations and uses thereof |
| GB201521101D0 (en) | 2015-11-30 | 2016-01-13 | Koninklijke Nederlandse Akademie Van Wetenschappen | Transduction buffer |
| ES2954596T3 (es) * | 2015-12-23 | 2023-11-23 | Univ British Columbia | Profármacos unidos a lípidos |
| WO2018160794A1 (en) | 2017-03-01 | 2018-09-07 | Merrimack Pharmaceuticals, Inc. | Epha2-targeted docetaxel -generating liposomes in combination with an agent that impedes regulatory t cell activity for treating cancer |
| CN109422759B (zh) * | 2017-08-22 | 2021-05-04 | 复旦大学 | 小分子修饰的紫杉烷类水溶性前药及其药用用途 |
| CN111004195B (zh) * | 2019-12-03 | 2022-01-28 | 沈阳药科大学 | 卡巴他赛弱碱性衍生物及其制剂 |
| WO2024010886A2 (en) * | 2022-07-07 | 2024-01-11 | Nanostar Pharmaceuticals Ltd. | Multilamellar vesicle drug formulation |
| CN117024381B (zh) * | 2023-08-14 | 2025-08-12 | 沈阳药科大学 | 卡巴他赛衍生物及其脂质体制剂 |
| CN118324842B (zh) * | 2024-04-10 | 2025-05-02 | 沈阳药科大学 | 地塞米松弱碱性衍生物及其制剂的制备及应用 |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2979518A (en) * | 1956-08-14 | 1961-04-11 | Organon | New steroid alaninates |
| GB1272841A (en) * | 1969-01-23 | 1972-05-03 | Leo Ab | New corticoid steroid compounds of cytostatic interest |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4443440A (en) * | 1982-08-30 | 1984-04-17 | The Upjohn Company | Amine containing ester prodrugs of corticosteroids |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| ATE92501T1 (de) * | 1984-10-04 | 1993-08-15 | Sandoz Ag | Monoklonale antikoerper gegen zyklosporine. |
| US4975282A (en) * | 1985-06-26 | 1990-12-04 | The Liposome Company, Inc. | Multilamellar liposomes having improved trapping efficiencies |
| US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
| US4837028A (en) * | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| JPH01117885A (ja) * | 1987-10-30 | 1989-05-10 | Dai Ichi Seiyaku Co Ltd | 新規ボドフィロトキシン誘導体及びその製造法 |
| ZA886810B (en) * | 1987-12-18 | 1989-08-30 | Bristol Myers Co | Epipodophyllotoxin glucoside 4'-acyl derivatives |
| US4942184A (en) * | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
| IL91664A (en) | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
| US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5534632A (en) * | 1991-09-05 | 1996-07-09 | Abbott Laboratories | Macrocyclic carbamate immunomodulators |
| US5457111A (en) * | 1991-09-05 | 1995-10-10 | Abbott Laboratories | Macrocyclic immunomodulators |
| US5563172A (en) * | 1991-09-05 | 1996-10-08 | Abbott Laboratories | Macrocyclic amide and urea immunomodulators |
| JPH069600A (ja) | 1992-05-06 | 1994-01-18 | Bristol Myers Squibb Co | タクソールのベンゾエート誘導体 |
| US5547981A (en) * | 1993-03-09 | 1996-08-20 | Enzon, Inc. | Taxol-7-carbazates |
| US5475011A (en) * | 1993-03-26 | 1995-12-12 | The Research Foundation Of State University Of New York | Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| WO1995011020A1 (en) * | 1993-10-20 | 1995-04-27 | Enzon, Inc. | 2'- and/or 7- substituted taxoids |
| US5489589A (en) * | 1994-12-07 | 1996-02-06 | Bristol-Myers Squibb Company | Amino acid derivatives of paclitaxel |
| JPH09110865A (ja) * | 1995-08-15 | 1997-04-28 | Masao Oguro | タキソール誘導体 |
| US6107332A (en) | 1995-09-12 | 2000-08-22 | The Liposome Company, Inc. | Hydrolysis-promoting hydrophobic taxane derivatives |
| ATE252372T1 (de) * | 1996-08-23 | 2003-11-15 | Sequus Pharm Inc | Liposome enthaltend cisplatin |
| GB9814527D0 (en) * | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
| HUP0201425A3 (en) * | 1999-04-23 | 2006-07-28 | Hadasit Med Res Service | Conjugate having a cleavable linkage for use in a liposome |
| FR2810321B1 (fr) * | 2000-06-20 | 2002-07-26 | Adir | Nouveaux derives de podophyllotoxine carbamate et thiocarbamate, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CA2424619C (en) * | 2000-10-04 | 2010-05-18 | Kyowa Hakko Kirin Co., Ltd. | Method for coating fine particles with lipid membrane |
| US6855720B2 (en) * | 2001-03-01 | 2005-02-15 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US6403604B1 (en) * | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| AU2002303164A1 (en) * | 2001-03-23 | 2002-10-08 | Protarga, Inc. | Fatty amine drug conjugates |
| AU2002312777B2 (en) * | 2001-03-27 | 2007-07-05 | Phares Pharmaceutical Research N.V. | Method and composition for solubilising a biologically active compound with low water solubility |
| GB0111279D0 (en) * | 2001-05-10 | 2001-06-27 | Nycomed Imaging As | Radiolabelled liposomes |
| ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
| US20050152962A1 (en) * | 2002-06-12 | 2005-07-14 | Metselaar Josbert M. | Composition for treatment of inflammatory disorders |
| JP2006508126A (ja) * | 2002-11-06 | 2006-03-09 | アザヤ セラピューティクス インコーポレイティッド | 薬学的製剤のタンパク質安定化されたリポソーム製剤 |
| US7342114B2 (en) * | 2003-07-01 | 2008-03-11 | California Pacific Medical Center | Podophyllotoxin derivatives |
| US8173840B2 (en) * | 2003-07-29 | 2012-05-08 | Signature R&D Holdings, Llc | Compounds with high therapeutic index |
| US20050095283A1 (en) | 2003-09-16 | 2005-05-05 | Aphios Corporation | Compositions and methods for topically treating diseases |
| WO2005030258A2 (en) * | 2003-09-22 | 2005-04-07 | Acidophil Llc | Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| EP1537858A1 (en) * | 2003-12-04 | 2005-06-08 | Vectron Therapeutics AG | Drug delivery vehicles and uses thereof |
| NZ589967A (en) * | 2004-01-14 | 2012-07-27 | Gilead Sciences Inc | Lipid-based dispersions useful for drug delivery |
| KR101462825B1 (ko) | 2004-05-03 | 2014-11-21 | 헤르메스 바이오사이언스, 인코포레이티드 | 약물 전달에 유용한 리포좀 |
| AU2005281352B2 (en) * | 2004-09-09 | 2011-01-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal compositions of glucocorticoid and glucocorticoid derivatives |
| JP2008518925A (ja) * | 2004-10-29 | 2008-06-05 | ネオファーム、インコーポレイティッド | リポソーム製剤の製造プロセス |
| JP4504845B2 (ja) * | 2005-03-11 | 2010-07-14 | テスコ・エコライティング株式会社 | 照明器具用下部反射板の取り付け具 |
| CA2601067A1 (en) * | 2005-05-04 | 2006-11-09 | Medigene Ag | Method of administering a cationic liposomal preparation comprising paclitaxel |
| EP1888033B1 (en) * | 2005-06-09 | 2014-02-19 | Meda AB | Method and composition for treating inflammatory disorders |
| CA2643826A1 (en) * | 2006-02-27 | 2008-06-12 | Paul A. Wender | Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| TW201509433A (zh) * | 2006-12-13 | 2015-03-16 | 斯茹林製藥公司 | 用於醫物傳遞之以環糊精為基之聚合物 |
| CN101029034B (zh) | 2007-03-30 | 2010-05-26 | 浙江大学 | 多烯紫杉醇水溶性衍生物及制备方法和用途 |
| JP5542804B2 (ja) * | 2008-05-23 | 2014-07-09 | ザ ユニヴァーシティ オブ ブリティッシュ コロンビア | リポソームナノ粒子中で使用するための修飾薬物 |
-
2009
- 2009-05-26 JP JP2011510067A patent/JP5542804B2/ja not_active Expired - Fee Related
- 2009-05-26 KR KR1020197012513A patent/KR20190049930A/ko not_active Ceased
- 2009-05-26 KR KR1020107028838A patent/KR101659457B1/ko not_active Expired - Fee Related
- 2009-05-26 US US12/993,482 patent/US8790691B2/en not_active Expired - Fee Related
- 2009-05-26 ES ES09750195.1T patent/ES2694481T3/es active Active
- 2009-05-26 CA CA2989616A patent/CA2989616A1/en not_active Abandoned
- 2009-05-26 CA CA2910133A patent/CA2910133C/en not_active Expired - Fee Related
- 2009-05-26 KR KR1020187003893A patent/KR101919093B1/ko not_active Expired - Fee Related
- 2009-05-26 WO PCT/IB2009/006532 patent/WO2009141738A2/en not_active Ceased
- 2009-05-26 CA CA2725535A patent/CA2725535C/en not_active Expired - Fee Related
- 2009-05-26 EP EP09750195.1A patent/EP2282724B1/en not_active Not-in-force
- 2009-05-26 EP EP18185021.5A patent/EP3415151A1/en not_active Withdrawn
- 2009-05-26 CN CN200980128975.XA patent/CN102105135B/zh not_active Expired - Fee Related
- 2009-05-26 KR KR1020167025450A patent/KR101830018B1/ko not_active Expired - Fee Related
- 2009-05-26 KR KR1020187032439A patent/KR101975843B1/ko not_active Expired - Fee Related
- 2009-05-26 CN CN201410836670.7A patent/CN104622809B/zh not_active Expired - Fee Related
-
2010
- 2010-11-18 IL IL209419A patent/IL209419A/en active IP Right Grant
-
2012
- 2012-05-08 US US13/467,021 patent/US8324410B2/en not_active Expired - Fee Related
-
2013
- 2013-04-19 US US13/866,913 patent/US8568772B2/en not_active Expired - Fee Related
- 2013-04-19 US US13/866,956 patent/US8545877B2/en not_active Expired - Fee Related
- 2013-04-19 US US13/866,873 patent/US8545876B1/en not_active Expired - Fee Related
- 2013-04-25 IL IL225961A patent/IL225961A/en active IP Right Grant
-
2014
- 2014-03-06 JP JP2014043564A patent/JP5744267B2/ja not_active Expired - Fee Related
- 2014-06-12 US US14/302,537 patent/US9968554B2/en not_active Expired - Fee Related
- 2014-07-17 JP JP2014146559A patent/JP5992019B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-16 JP JP2016159491A patent/JP6437968B2/ja not_active Expired - Fee Related
-
2018
- 2018-04-09 US US15/948,716 patent/US20180221279A1/en not_active Abandoned
- 2018-11-15 JP JP2018214441A patent/JP2019048851A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Skwarczynski et al. | Paclitaxel prodrugs: toward smarter delivery of anticancer agents | |
| TWI394774B (zh) | Novel block copolymers, microcell modifiers, and anticancer agents that are useful as an active ingredient | |
| JP2022506299A5 (enExample) | ||
| CA3145109A1 (en) | Cannabinoid conjugate molecules | |
| JP2009542716A5 (enExample) | ||
| JP2017531041A5 (enExample) | ||
| CN107660210B (zh) | 基于硼替佐米的递送系统 | |
| MX2010003868A (es) | Cis-imidazolinas quirales. | |
| CA2583700A1 (en) | Quinone prodrug compositions and methods of use | |
| BRPI0708299A2 (pt) | composições e métodos para o transporte de moléculas com propriedades melhoradas de liberação através de barreiras biológicas | |
| ES2774662T3 (es) | Derivados de Pt (IV) y nanotransportadores que los comprenden | |
| WO2006055747A3 (en) | Bis(thio-hydrazide amides) for increasing hsp70 expression | |
| MX2007012688A (es) | Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida. | |
| Saleh et al. | Cucurbiturils in drug delivery and for biomedical applications | |
| WO2014204856A1 (en) | Fatty acid anticancer derivatives and their uses | |
| US20250367312A1 (en) | Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer | |
| Wierzba et al. | Synthetic approaches toward vitamin B12 conjugates | |
| RU2009114731A (ru) | Производное пиразолопиримидина | |
| US9566351B2 (en) | Molecular containers and methods of making and using same | |
| US11311625B2 (en) | Peptide-based multiple-drug delivery vehicle | |
| JP2010535204A5 (enExample) | ||
| US8614228B2 (en) | Quinone prodrug compositions and methods of use | |
| CN109563215A (zh) | 聚合物连接子及其用途 | |
| US12453711B2 (en) | Platinum complex anti-neoplastic agents comprising a cannabinoid ligand | |
| JP2006518726A5 (enExample) |